FDA Inspection
QuVa Pharma, Inc.QuVa Pharma, Inc. – FDA Inspection, Mar 14, 2019
Record Details
This FDA Inspection record concerns QuVa Pharma, Inc., with an inspection on March 14, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e60e1f85-431b-4b4b-bb92-fb5e02991b0f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1083122
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of QuVa Pharma, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2018 | Not classified | Dallas District Office | Drug Quality Assurance |
| December 8, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 20, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for QuVa Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.